It has been also reported that gastric cancer patients with elevated levels of Smad7 had a poor prognosis independently of other well-established clinical prognostic factors, such as tumor size, depth of invasion and lymph node metastasis [51]. Here, SMAD7 is linked to metastatic malignant neoplasm in the lymph nodes.